Identification of genetic biomarkers to predict the response to nutritional therapy in patients with Type 2 Diabetes
Authors:
- Domenica Monserrath Robayo PovedaDPDomenica Monserrath Robayo Poveda
- Nathaly Michelle Sánchez GuarnizoNGNathaly Michelle Sánchez Guarnizo
- Ángel Rafael Balarezo MontañoÁMÁngel Rafael Balarezo Montaño
- Carlos Fabian Argotti ZumbanaCZCarlos Fabian Argotti Zumbana
- Edison Joshua Jijón SánchezESEdison Joshua Jijón Sánchez
- María de Lourdes Larrea ParedesMPMaría de Lourdes Larrea Paredes
- Doris Jeanneth Jiménez DuranDDDoris Jeanneth Jiménez Duran
- Jonathan Luis Cruz PierardJPJonathan Luis Cruz Pierard
- Stephanie Marie Cruz PierardStephanie Marie Cruz Pierard
- Oscar Isidro Sánchez GanchozoOGOscar Isidro Sánchez Ganchozo
Open Access
- 13 January 2025
- journal article
- Published by Salud, Ciencia y Tecnologia in Salud, Ciencia y Tecnología
- Vol. 5, 1290
Abstract
Introduction: The identification of genetic biomarkers to predict the response to nutritional therapy in patients with type 2 diabetes (T2D) has become a promising area to improve the response to therapeutic interventions. In addition, biomarkers are of great help as biological determinants, to study, evaluate and determine Diabetes Mellitus 2. Objective: To analyze the genetic biomarkers associated with the response to nutritional therapy in patients with type 2 diabetes, in order to contribute to the development of personalized strategies that optimize metabolic control and improve the effectiveness of nutritional treatment. Methodology: Systematic review based on PRISMA. 15 studies published between 2018-2023 in databases such as PubMed, Scopus, Scielo, etc. were included. The inclusion criteria were articles on genetic biomarkers, original, systematic review, case studies. Publications prior to 2017, theses and duplicate articles, articles without free access were excluded. Results: The findings highlight the importance of polygenic markers and epigenetic factors, such as DNA methylation, in predicting therapeutic outcomes. Furthermore, the influence of dietary patterns on biomarker expression emphasizes the potential of personalized nutritional strategies in the management of type 2 diabetes. Conclusion: Despite advances in biomarker research, further studies are needed, particularly in Latin American populations, to develop effective interventions tailored to genetic profiles. This study underscores the importance of integrating genetic and environmental factors to improve clinical outcomes in the treatment of type 2 diabetesKeywords
This publication has 11 references indexed in Scilit:
- A nutritional biomarker score of the Mediterranean diet and incident type 2 diabetes: Integrated analysis of data from the MedLey randomised controlled trial and the EPIC-InterAct case-cohort studyPLOS Medicine, 2023
- Genetically Guided Mediterranean Diet for the Personalized Nutritional Management of Type 2 Diabetes MellitusNutrients, 2021
- A cross-platform approach identifies genetic regulators of human metabolism and healthNature Genetics, 2021
- Association of plasma biomarkers of fruit and vegetable intake with incident type 2 diabetes: EPIC-InterAct case-cohort study in eight European countriesBMJ, 2020
- Biomarkers for type 2 diabetesMolecular Metabolism, 2019
- Nutritional Factors, DNA Methylation, and Risk of Type 2 Diabetes and Obesity: Perspectives and ChallengesInternational Journal of Molecular Sciences, 2019
- Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT ConsortiumDiabetologia, 2019
- Diagnosis of obesity and use of obesity biomarkers in science and clinical medicineMetabolism, 2019
- MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targetsClinical Science, 2019
- A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV studyExperimental & Molecular Medicine, 2018